ArticleFrontiers in bioengineering and biotechnology2022

Dynamic alteration in SULmax predicts early pathological tumor response and short-term prognosis in non-small cell lung cancer treated with neoadjuvant immunochemotherapy.

Taotao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.